Home › Funds › Exome Asset Management LLC › CRBP

Exome Asset Management LLC position in CRBP

CORBUS PHARMACEUTICALS · Health Care

Exome Asset Management LLC reported holding 184,914 shares of CRBP (CORBUS PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$1.7M, representing 1.07% of its reported portfolio and ranking #36 among its reported holdings. Exome Asset Management LLC has disclosed CRBP holdings in 8 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)184.91K sh
Reported value held$1.73M
Portfolio Weight1.07%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Exome Asset Management LLC's CRBP position evolved

Exome Asset Management LLC first disclosed a stake in CRBP in Q1 2024 at 87,846 shares (US$3.4M). The position peaked in Q2 2024 at 84,790 shares, worth US$3.8M. Across 8 filings, Exome Asset Management LLC increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 184,914 shares valued at US$1.7M — a reduction of -49,222 shares quarter over quarter.. Notable position changes include a 39% trim in Q4 2025 (shares rose 15% over the following quarter), a 68% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 87.85K $3.45M New
Q2 2024 84.79K $3.84M Reduce
Q1 2025 289.69K $1.54M New
Q2 2025 277.32K $1.91M Reduce
Q3 2025 229.96K $2.91M Reduce
Q4 2025 139.54K $1.14M Reduce
Q1 2026 234.14K $2.20M Add
Q2 2026 184.91K $1.73M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRBP and 13F data

CRBP (CORBUS PHARMACEUTICALS) is a Health Care company. 24 other funds we track also report a position in CRBP — the largest reported positions include Cormorant Asset Management, LP (US$22.0M), Jones Hill Capital LP (US$6.1M), Prosight Management, LP (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRBP

All CRBP fund holders →

FAQ

How long has Exome Asset Management LLC held CRBP?

Exome Asset Management LLC has disclosed CRBP holdings in 8 of the last 10 reported quarters, going back to Q1 2024.

What is Exome Asset Management LLC's current position in CRBP?

As of Q2 2026, Exome Asset Management LLC holds 184.91K shares of CRBP (CORBUS PHARMACEUTICALS), valued at $1.73M, representing 1.07% of its reported portfolio and ranking #36.

Has Exome Asset Management LLC been buying or selling CRBP?

In the latest 13F filing (Q2 2026), Exome Asset Management LLC reduced its position in CRBP. The position peaked in Q2 2024 at 84.79K shares.

Which other funds hold CRBP?

Other major institutional holders of CRBP include Cormorant Asset Management, LP, Jones Hill Capital LP, Prosight Management, LP, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.